Vycor Medical (VYCO) Other Non-Current Assets (2010 - 2026)
Vycor Medical's (VYCO) quarterly Other Non-Current Assets came in at $86896.0 in Q1 2026, up 1348.27% year-on-year from $6000.0 in Q1 2025, and up 7679.41% on a QoQ basis from $1117.0 in Q4 2025.
Vycor Medical (VYCO) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Other Non-Current Assets data on file, last reported at $86896.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 1348.27% year-over-year to $86896.0 in Q1 2026; TTM through Mar 2026 was $86896.0, a 1348.27% increase from a year earlier, with the FY2025 full-year figure at $1117.0, up 21.81% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $86896.0, up from $1117.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for VYCO reached as high as $160253.0 in Q2 2025 and fell as low as $896.0 in Q3 2023.
- Historically, Other Non-Current Assets has averaged $18119.4 across 5 years, with a median of $6000.0 in 2022.
- Across the five-year window, Other Non-Current Assets plunged 85.07% in 2023 and surged 15657.42% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then slumped by 84.72% to $917.0 in 2024, then climbed by 21.81% to $1117.0 in 2025, then surged by 7679.41% to $86896.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $86896.0 in Q1 2026, $1117.0 in Q4 2025, and $1425.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 86,896.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86,896.00 |
| Dec 31, 2025 | 1,117.00 |
| Sep 30, 2025 | 1,425.00 |
| Jun 30, 2025 | 160,253.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 917.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 1,017.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 896.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 1,508.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 380.00 |
| Sep 30, 2021 | 339.00 |
| Jun 30, 2021 | 506.00 |